Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies? - Wikidata - awgldk - TriplyDB

Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

http://www.wikidata.org/entity/Q37662448

about

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke Brain health and shared risk factors for dementia and stroke.Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis.Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.Initial Investigation into Microbleeds and White Matter Signal Changes following Radiotherapy for Low-Grade and Benign Brain Tumors Using Ultra-High-Field MRI Techniques.Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes.Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk.Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.Updates on Prevention of Hemorrhagic and Lacunar Strokes.A user-guided tool for semi-automated cerebral microbleed detection and volume segmentation: Evaluating vascular injury and data labelling for machine learning

P2860

Q30414441-D5BA42C5-CE31-424A-8A98-A2F3FF5F2D81 Q31007958-1609CE0F-D85E-42B9-B994-D444AF216599 Q38389058-F0B3BD1E-82CC-4E34-AA86-475CE2495AAF Q38682349-AA3157D9-AF2A-4836-A2AE-E4648ADC7896 Q45425671-85910653-4156-4FE8-AC78-5BDE1144DDDE Q47918712-CC790F34-B66C-477D-984B-189842D5CDCB Q49428555-FC9F844C-AC1A-4ABE-A371-60B98EC1DDE8 Q49920953-0C791D4B-6C75-4218-B31D-E7BEEAC78654 Q50082239-EF02436B-1849-48AB-9459-24CAA93590D8 Q55400701-EC181A27-4389-45C2-AC0E-90C53F71CC5C Q58800528-B3226F8D-6D69-47EB-868F-2B3B0DF65DB8

P2860

Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

http://www.wikidata.org/entity/Q37662448

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@en

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@nl

type

label

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@en

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@nl

prefLabel

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@en

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@nl

P1433

Q37662448-E7422F1B-3778-4C5B-8585-B895F22A1E71

P1476

Q37662448-AA72FFCA-CA95-4490-83F2-3E5ACF3120E6

P2093

Q37662448-1639795E-5B9A-42D4-BF58-2BF03A0344C7

Q37662448-509CCF85-C7EC-4917-9DFF-C8D6ADAB7194

P2860

Q37662448-019767FF-8ED3-47E3-9F7E-2A6FEA13F432

Q37662448-049F1B41-D891-4564-97DD-3DEE91D33385

Q37662448-0781C817-706B-4D51-87A9-60A869B62933

Q37662448-1997DB6A-1303-404D-ABFE-0339B2B20516

Q37662448-1FB20D13-465E-4E70-B682-C7E9C008433D

Q37662448-29B797A9-8C47-4965-BC8A-DCCFFC15D17D

Q37662448-2AB25309-9D4C-4089-9628-2658F27D4738

Q37662448-2B6C39E3-C3F6-4476-994A-227028245C2E

Q37662448-2D1C5F9B-85DF-4BE7-9158-B4AE547185BB

Q37662448-2E06A5EE-CB24-45A9-8472-F2B381838349

P2888

Q37662448-A0FDEBE2-3C01-40AD-8FFC-511ED8FCE7AF

P304

Q37662448-908960CC-B372-4836-81D2-9E9E849C64FC

P31

Q37662448-3862B8CB-3BD7-4609-B0EB-B23E04849EF7

P356

Q37662448-FB09A199-270E-47B9-A8A5-8A04960D0D3D

P433

Q37662448-91D596B8-2A38-4F00-8FC2-2A6047D67B2A

P478

Q37662448-2336D761-0696-4783-BE76-4CCF432244A6

P50

Q37662448-3C3F0A46-2BBA-4DA3-BAFA-7E0EC4001738

P577

Q37662448-C0BB1B08-B7F1-493F-8DAA-D38040CF9693

P698

Q37662448-17083958-1D39-4E3B-88CC-483784C6B8BD

P932

Q37662448-A996C495-831B-406F-9F9E-8054F0659220

P356

S11886-013-0425-8

P1433

Current cardiology reports

P1476

Cerebral microbleeds and macro ...... for antithrombotic therapies?

@en

P2093

Kellen E Haley

http://www.w3.org/2001/XMLSchema#string

Steven M Greenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank.

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

P2888

s11886-013-0425-8

P304

425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-013-0425-8

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Mahmut Edip Gurol

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24122195

http://www.w3.org/2001/XMLSchema#string

P932

3965371

http://www.w3.org/2001/XMLSchema#string